Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M

NCT05474118 is registered in ClinicalTrials.gov with Centre Hospitalier Annecy Genevois as lead sponsor.

NCT NCT05474118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M
Lead sponsor
Centre Hospitalier Annecy Genevois
Phase
Observational
Overall status
Completed
Start date
February 5, 2020
Completion date
March 31, 2022
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocarditis, infectious disease